Search

Abou Coulibaly,1 Tieba Millogo,2 Adama Baguiya,1 Nguyen Toan Tran,3 Blandine Thieba,4 Armando Seuc,5 Asa Cuzin-Kihl,5 Sihem Landoulsi,5 James Kiarie,5 Rachel Yodi,6 Désiré Mashinda,6 Séni Kouanda1 1Institut de Recherche en Sciences de la Santé (IRSS), Département Biomédical et Santé Publique, Ouagadougou, Burkina Faso; 2Institut Africain de Santé Publique, Ouagadougou, Burkina Faso; 3University of Technology, Faculty of Health, Australian Centre for Public and Population Health Research, Sydney, Australia; 4Université Joseph KI-ZERBO, Unité de Formation et de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso; 5World Health Organization, Department of Reproductive Health Research, Geneva, Switzerland; 6Université de Kinshasa, Ecole de Santé Publique, Kinshasa, République Démocratique du CongoCorrespondence: Abou CoulibalyInstitut de Recherche en Sciences de la Santé (IRSS), 03 B.P. 7047, Ouagadougou, 03, Burkina FasoTel +226 71 40 77 89Email samsoncoul@gmail.comPurpose: An earlier adoption of contraceptive methods during the postpartum period could help women to extend the inter-pregnancy interval. This article aimed to determine and compare the timing of long-acting reversible contraceptives (LARC) use (ie, intrauterine device and implant) in Burkina Faso (BF) and DR Congo (DRC) between the intervention and control groups.Patients and Methods: A total of 1120 postpartum women were enrolled and followed up to 12 months postpartum. We used Yam-Daabo trial data which was a multi-intervention, single-blinded, cluster-randomised controlled trial done in primary health-care centres (clusters) in both countries. Centres were randomly allocated to receive the six-component intervention or standard antenatal and postnatal care in matched pairs (1:1). We did a secondary analysis using Royston